King KE, Shirey RS, Lankiewicz MW, Young-Ramsaran J, Ness PM. Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients’ red cells. Transfusion 1997;37:376–81.10.1046/j.1537-2995.1997.37497265337.xSearch in Google Scholar
Petz LD.Bystander immune cytolysis.Transfus Med Rev 2006;20:110–40.10.1016/j.tmrv.2005.11.002Search in Google Scholar
Petz LD,Calhoun L,Shulman IA,Johnson C,Herron RM.The sickle cell hemolytic transfusion reaction syndrome.Transfusion 1997;37:382–92.10.1046/j.1537-2995.1997.37497265338.xSearch in Google Scholar
Talano JA, Hillery CA, Gottschall JL, Baylerian DM, Scott JP. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Pediatrics 2003;111:e661–5.10.1542/peds.111.6.e661Search in Google Scholar
Win N, Doughty H, Telfer P, Wild BJ, Pearson TC. Hyperhemolytic transfusion reaction in sickle cell disease.Transfusion 2001;41:323–8.10.1046/j.1537-2995.2001.41030323.xSearch in Google Scholar
Cullis JO,Win N,Dudley JM,KayeT.Post-transfusion hyperhaemolysis in a patient with sickle cell disease: use of steroids and intravenous immunoglobulin to prevent further red cell destruction. Vox Sang 1995;69:355–7.10.1111/j.1423-0410.1995.tb00373.xSearch in Google Scholar
Telen MJ.Principles and problems of transfusion in sickle cell disease.Semin Hematol 2001;38:315–23.10.1016/S0037-1963(01)90025-3Search in Google Scholar
Win N,Yeghen T, Needs M, Chen FE, Okpala I. Use of intravenous immunoglobulin and intravenous methylprednisolone in hyperhaemolysis syndrome in sickle cell disease. Hematology 2004;9:433–6.10.1080/1024533040000192615763986Search in Google Scholar
Olteanu H, Gerber D, Partridge K, et al. Acute hemolytic transfusion reaction secondary to anti-Fy3. Immunohematology 2005;21:48–52.10.21307/immunohematology-2019-392Search in Google Scholar
Aygun B,Padmanabhan S,Paley C,Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.Transfusion 2002;42:37–43.10.1046/j.1537-2995.2002.00007.x11896310Search in Google Scholar
Cox JV,Steane E,Cunningham G,Frenkel EP.Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease. Arch Intern Med 1988;148:2485–9.10.1001/archinte.1988.00380110115024Search in Google Scholar
Rosse WF,Gallagher D,KinneyTR,et al.Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood 1990;76:1431–7.10.1182/blood.V76.7.1431.1431Search in Google Scholar
Chaplin H,Cassell M.The occasional fallibility of in vitro compatibility tests. Transfusion 1962;2: 375–84.10.1111/j.1537-2995.1962.tb00260.x14020134Search in Google Scholar
Garratty G. Severe reactions associated with transfusion of patients with sickle cell disease. Transfusion 1997;37: 357–61.10.1046/j.1537-2995.1997.37497265334.x9111271Search in Google Scholar
Diamond WJ, Brown FL Jr, Bitterman P, Klein HG, Davey RJ, Winslow RM. Delayed hemolytic transfusion reaction presenting as sickle-cell crisis. Ann Intern Med 1980;93:231–4.10.7326/0003-4819-93-2-2317406372Search in Google Scholar
Milner PF,Squires JE,Larison PJ,Charles WT,Krauss JS. Posttransfusion crises in sickle cell anemia: role of delayed hemolytic reactions to transfusion. South Med J 1985;78:1462–9.10.1097/00007611-198512000-000164071176Search in Google Scholar
Test ST, Woolworth VS. Defective regulation of complement by the sickle erythrocyte: evidence for a defect in control of membrane attack complex formation. Blood 1994;83:842–52.10.1182/blood.V83.3.842.842Search in Google Scholar
Lubin B, Chiu D, Bastacky J, Roelofsen B, Van Deenen LL.Abnormalities in membrane phospholipid organization in sickled erythrocytes. J Clin Invest 1981;67:1643–9.10.1172/JCI1102003707397240412Search in Google Scholar
Schwartz RS,Tanaka Y, Fidler IJ, Chiu DT, Lubin B, Schroit AJ. Increased adherence of sickled and phosphatidylserine-enriched human erythrocytes to cultured human peripheral blood monocytes. J Clin Invest 1985;75:1965–72.10.1172/JCI1119134255554008648Search in Google Scholar
Grainger JD, Makar Y, McManus A, Wynn R. Refractory hyperhaemolysis in a patient with beta-thalassaemia major.Transfus Med 2001;11:55–7.10.1046/j.1365-3148.2001.00278.x11328573Search in Google Scholar
Garratty G. Immune hemolytic anemia associated with negative routine serology. Semin Hematol 2005;42:156–64.10.1053/j.seminhematol.2005.04.00516041665Search in Google Scholar
Tournamille C, Colin Y, Cartron JP, Le Van Kim C. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 1995;10: 224–8.10.1038/ng0695-2247663520Search in Google Scholar
Peiper SC, Wang ZX, Neote K, et al. The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J Exp Med 1995;181:1311–7.10.1084/jem.181.4.131121919617699323Search in Google Scholar
Mallinson G, Soo KS, Schall TJ, Pisacka M,Anstee DJ. Mutations in the erythrocyte chemokine receptor (Duffy) gene: the molecular basis of the Fya/Fyb antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy(a–b–) phenotype. Br J Haematol 1995;90: 823–9.10.1111/j.1365-2141.1995.tb05202.x7669660Search in Google Scholar
Ballas SK,Marcolina MJ.Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia. Transfusion 2006;46:105–10.10.1111/j.1537-2995.2006.00679.x16398738Search in Google Scholar
